ArticleFrontiers in cardiovascular medicine2025
A positive linear correlation between the triglyceride-glucose index and in-stent restenosis after percutaneous coronary intervention in patients with coronary heart disease.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Triglyceride levels and all-cause mortality in patients with left main coronary artery disease undergoing percutaneous coronary intervention.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: The association between the triglyceride-glucose (TyG) index and in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD) remains inadequately explored. This study aimed to evaluate the relationship between TyG and ISR in patients with CHD following PCI. Methods: This retrospective study included 519 patients with CHD undergoing PCI. TyG, considered as the exposure variable, was divided into lower (≤9.21) and higher (>9.21) groups based on the optimal cutoff determined by receiver operator characteristic (ROC) analysis, with ISR as the outcome variable. Multivariable logistic regression, subgroup analysis, ROC analysis and restricted cubic spline (RCS) modeling were used to assess the association between TyG and ISR. Results: Patients with higher TyG had a significantly greater incidence of ISR compared to patients with lower TyG ( Conclusion: A higher TyG index is significantly associated with an increased risk of ISR in CHD after PCI, highlighting its potential as a valuable biomarker for cardiovascular risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.